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Methods 
Fabrication of nanostraw microdevices. Unless otherwise noted, all materials were 
purchased from Sigma-Aldrich (St. Louis, MO). First, two layers of 110 mg/mL 950 kDa 
PMMA (MicroChem) in anisole were deposited onto a 3-inch-diameter <111> silicon wafer 
(Addison Engineering) by spin casting at 1350 rpm and curing at 110 °C for 1 min. Microposit 
S1818 photoresist (MicroChem) was spun cast over the PMMA at 2500 rpm and cured at 110 °C 
for 1 min. The photoresist was exposed to 225 mJ/cm
2
 of UV light through a computer-designed 
photomask with arrays of opaque annuli (200 µm outer diameters, 100 µm inner diameters, 400 
µm pitch). The photoresist was submerged in 351 Developer (MicroChem) diluted 1:3 in dH2O 
for 2 min under gentle shaking. The 8 µm PMMA layer was anisotropically etched with oxygen 
plasma (450 W, 250 mTorr, 6.5 min) by 5.5 µm in regions not protected by photoresist. The 
remaining photoresist was removed by submerging in Microposit Remover 1112A (MicroChem) 
for 2 min and then rinsing with dH2O. A wafer previously spun cast with 75 mg/mL 80 kDa PCL 
in trifluoroethanol at 1750 rpm was brought into contact with the microdevices on a hot plate at 
80 °C, and the wafers were quickly separated. Nanostraw membranes were fabricated as 
previously described,
1
 with minor modifications. Briefly, track-etch polycarbonate membranes 
with densities of either 10
7
 cm
-2
 (AR Brown Global) or 3 × 10
7
 cm
-2
 (GVS, Sanford, ME) and 
varying pore diameters were coated with aluminum oxide by atomic layer deposition, and the 
aluminum oxide layer was anisotropically etched by reactive ion etching with BCl3 and Cl2 in 
Argon (300 W, 40 sccm BCl3, 30 sccm Cl2, 5 mTorr, 5 min) on both sides of the membrane, 
waiting until the final fabrication step to expose the nanostraws by etching PC with oxygen 
plasma. The membrane was then brought into contact with the microdevices at 80 °C, melting 
the PCL and bonding the membrane to the devices. The membrane was spun cast with two layers 
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of 75 mg/mL PVA at 2500 rpm, curing at 95 °C for 1 min after each deposition. SU-8 2015 
(MicroChem) was then spun cast at 1250 rpm and cured at 95 °C for 5 min. The SU-8 was 
exposed to 250 mJ/cm
2
 of UV light through an opaque photomask with 200 µm transparent 
circles aligned to the microdevices and then baked at 95 °C for 5 min. The devices were 
submerged in SU-8 Developer (MicroChem) for 5 min under gentle shaking and dried with a 
nitrogen gun. The membrane overhang and remaining PMMA between microdevices were 
removed by etching with oxygen plasma (450 W, 250 mTorr, 40 min). The devices were rinsed 
in dH2O, dissolving the PVA and allowing the SU-8 caps to detach. The nanostraws were then 
exposed by partially etching the surrounding polycarbonate with oxygen plasma at a lower 
energy (100 W, 250 mTorr, 20 min). 
Device profilometry. Device height profiles were measured with an Ambios XP2 
profilometer at various fabrication steps to determine nanostraw microdevice dimensions. 
Specifically, the height profiles of microdevices with etched PMMA after removal of photoresist, 
etched PMMA coated with PCL, and complete nanostraw microdevices were measured over the 
center of the devices. The thicknesses of the nanostraw membrane (following etching to expose 
nanostraws) and the PMMA base layer were also measured via profilometry. The PMMA base 
layer was scratched to expose the underlying silicon wafer prior to measurement. To account for 
the thickness of PMMA yet to be etched in remaining fabrication steps, the thickness of the 
PMMA base layer was added to the height profiles of the etched PMMA devices and the etched 
PMMA devices coated with PCL. The profile of the base of the nanostraw membrane was 
determined by subtracting the thickness of the nanostraw membrane from the profile of complete 
devices.  
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Quantification of nanostraw density heterogeneity at the cellular scale. Caco-2 cells 
were cultured as previously described to facilitate formation of a cellular monolayer.
2
 SEM 
imaging indicated that the Caco-2 cells could be approximated as having edge lengths on the 
order of 10 µm. A nanostraw membrane (inner nanostraw diameter: 60 nm, nanostraw density: 
10
7
 cm
-2
) was imaged with SEM. The SEM images were divided into 10 µm × 10 µm regions, an 
approximation of the dimensions of intestinal epithelial cells. The number of nanostraws 
contained within each of 100 analyzed regions was determined and plotted as a histogram 
showing the number of regions containing a given number of nanostraws. 
Confocal fluorescence imaging to compare the amount of adsorbed FITC-insulin to 
the amount of in-solution FITC-insulin in device reservoirs. Nanostraw microdevices (inner 
nanostraw diameter: 60 nm, nanostraw density: 10
7
 cm
-2
) were incubated in 10 mg/mL FITC-
insulin at 4 °C for 48 h and then washed in PBS for 1 min. The devices were imaged with 
confocal fluorescence microscopy, collecting images with 2 µm z-steps over the entire device 
reservoirs. The devices were incubated in 37 °C PBS for 24 h to facilitate drug release and 
imaged again under identical conditions.  
Testing nanostraw microdevice retention of drug following detachment of 
microdevices from the silicon wafer. Microdevices were incubated in a PBS solution of 10 
mg/mL FITC-insulin overnight, rinsed with PBS, and scraped from the wafer with a razor. 
Microdevices were then loaded into a channel formed by placing a 1.5 × 24 × 0.12 mm adhesive 
spacer (Grace Bio-labs) between a glass slide and coverslip. The microdevices were incubated at 
room temperature for approximately 30 min and then imaged with brightfield and fluorescence 
microscopy. 
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 Determining if device reservoirs become saturated with FITC-dextran after 
incubation for 48 h. Nanostraw microdevices were incubated in 1 mg/mL FITC-dextran and 
analyzed with confocal microscopy as performed for the FITC-dextran influx assay, except the 
timepoints used were 48 and 72 h. 
 Determining total nanostraw microdevice drug capacity. Devices were loaded with 10 
mg/mL FITC-insulin and monitored for drug release as described previously except the mass of 
drug released was determined at 48 h, after which time no significant drug release was detected. 
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Figures 
 
Figure S1. Height profiles of microdevices at various stages of fabrication. Height profiles 
show thicknesses of approximately 2.5 µm for the PMMA base layer, 7.5 µm for drug reservoirs, 
7 µm for nanostraw membranes (following etching to expose nanostraws), and 17 µm for total 
device thickness (not accounting for nanostraw length). PCL thickness was 5 µm before 
nanostraw membrane bonding and 1 − 2 µm following compression during bonding. 
 
 
 
 
 
 
 7 
 
Figure S2. Quantification of heterogeneity in nanostraw density at the cellular scale. A. 
SEM imaging demonstrated that the cuboidal Caco-2 intestinal epithelial cells can be 
approximated as having edge lengths on the order of 10 µm. B. To determine the heterogeneity 
in nanostraw distribution at the cellular scale, SEM images of a nanostraw membrane (inner 
nanostraw diameter: 60 nm, nanostraw density: 10
7
 cm
-2
) were analyzed by quantifying the 
number of nanostraws within 10 µm × 10 µm regions (outlined in red). C. A histogram showing 
the number of regions containing a given number of nanostraws. There was a mean of 10 ± 3 
nanostraws per 10 µm × 10 µm region (n = 100). 
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Figure S3. FITC-insulin adsorption to devices is minimal relative to the amount of FITC-
insulin loaded within device reservoirs. A. Images of nanostraw microdevices loaded with 
FITC-insulin and washed in PBS for 1 min. show that the fluorescence intensity of FITC-insulin 
adsorbed onto the surfaces of the devices (outlined in dotted red lines) is much lower than that of 
drug in solution within the device reservoirs, demonstrating that the 1 min wash in PBS was 
effective in removing non-loaded insulin from the external surfaces of the devices. B. The 
devices were imaged under identical conditions after the drug had been released in PBS at 37 °C 
for 24 hours, and the fluorescence intensity of FITC-insulin remaining adsorbed onto the 
surfaces of the devices was much lower than the amount of FITC-insulin that was previously 
loaded into device reservoirs, demonstrating that FITC-insulin adsorption to internal device 
surfaces is also minimal relative to the amount of loaded drug. 
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Figure S4. Loaded nanostraw microdevices retain drug after detachment from the silicon 
wafer. Nanostraw microdevices were incubated in a PBS solution of 10 mg/mL FITC-insulin 
overnight, rinsed with and submerged in PBS, and scraped from the silicon wafer with a razor. 
The PBS-suspended microdevices were added to a chamber formed by placing an adhesive 
spacer between a glass slide and a coverslip and incubated at room temperature for 30 min. The 
microdevices were then imaged for structure (brightfield signal, shown in grayscale) and FITC-
insulin localization (fluorescence signal, shown in green). FITC-insulin remained within the 
device reservoirs, indicating that the devices remained sealed following detachment from the 
silicon wafer. 
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Figure S5. Device reservoirs become saturated with FITC-dextran after incubation for 48 h. 
A. Nanostraw microdevices used for the influx assay were incubated at 37 °C in 1 mg/mL FITC-
dextran (10 kDa) for 48 or 72 h and then imaged with confocal microscopy. B. The fluorescence 
intensity values at 48 and 72 h were statistically similar, indicating that the device reservoirs had 
equilibrated with the external 1 mg/mL  FITC-dextran solution by 48 h. 
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Figure S6. FITC-insulin release over time expressed as a percentage of the total amount of drug 
loaded into microdevices. 
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